Expression and clinical significance of miRNA-145 and miRNA-218 in laryngeal cancer
Authors:
Open Access
- 13 May 2019
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 18 (1) , 764-770
Abstract
Expression of miRNA-145 and miRNA-218 in serum of patients with laryngeal cancer and the relationship between them and the clinicopathological parameters and prognosis were investigated. The clinical medical records of 132 patients with laryngeal cancer, who were admitted to Guangdong Second Provincial General Hospital from February 2009 to March 2014, were retrospectively analyzed and comprised the study group. The data of physical examinations of 56 healthy volunteers who took physical examinations in the same hospital comprised the control group. RT-qPCR was used to detect the expression levels of miRNA-145 and miRNA-218 in serum of the patients in the two groups. According to the relative expression levels of miRNA-145 and miRNA-218 in serum of the patients in the study group on the day when they left hospital, the study group was divided into the high expression group (n=73 patients) and the low expression group (n=59 patients). The patients received a 48-month follow-up visit and their survival condition was recorded and the Kaplan-Meier was used to carry out the survival analysis. The expression levels of miRNA-145 and miRNA-218 in serum of the patients in the study group were lower than those in the control group (P<0.05). The median survival time of the patients in the high expression group was 30 months while the median survival time of the patients in the low expression group was 26 months. The expression levels of miRNA-145 and miRNA‑218 in serum of patients with laryngeal cancer decreased, the higher the expression levels of miRNA‑145 and miRNA-218 in serum of patients with laryngeal cancer were, the better the prognosis was. miRNA-145 and miRNA‑218 were used as indicators of assessing the prognosis of patients with laryngeal cancer.Keywords
This publication has 23 references indexed in Scilit:
- The role of MicroRNAs expression in laryngeal cancerOncotarget, 2015
- MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1Tumor Biology, 2015
- Role of miR-145 in human laryngeal squamous cell carcinomaHead & Neck, 2014
- MicroRNA Regulation of Mitogenic Signaling Networks in the Human PlacentaJournal of Biological Chemistry, 2014
- Aerodigestive cancers: laryngeal cancer.2014
- RETRACTED ARTICLE: MicroRNA-145 inhibits tumour growth and metastasis in colorectal cancer by targeting fascin-1British Journal of Cancer, 2014
- Reduced expression of circulating microRNA-218 in gastric cancer and correlation with tumor invasion and prognosisWorld Journal of Gastroenterology, 2014
- The Role ofH. pyloriin the Development of Laryngeal Squamous Cell CarcinomaDisease Markers, 2013
- miR-218 Suppresses Nasopharyngeal Cancer Progression through Downregulation of Survivin and the SLIT2-ROBO1 PathwayCancer Research, 2011
- MicroRNAs in Pancreatic Ductal Adenocarcinoma: New Diagnostic and Therapeutic CluesPancreatology, 2009